#METABOLOMICS WORKBENCH YjChern_20250828_201310 DATATRACK_ID:6345 STUDY_ID:ST004164 ANALYSIS_ID:AN006913 PROJECT_ID:PR002624 VERSION 1 CREATED_ON September 2, 2025, 8:11 pm #PROJECT PR:PROJECT_TITLE Equilibrative Nucleoside Transporter 2 Modulates Inosine Catabolism to Influence PR:PROJECT_TITLE Astrocyte Metabolism and Reactivity PR:PROJECT_SUMMARY Astrocytes are central regulators of brain function and exhibit diverse reactive PR:PROJECT_SUMMARY states in response to injury and inflammation. Although the mechanisms PR:PROJECT_SUMMARY underlying these states remain debated, cellular energy metabolism is thought to PR:PROJECT_SUMMARY play a crucial role. This project aimed to define the role of equilibrative PR:PROJECT_SUMMARY nucleoside transporter 2 (Ent2) in regulating astrocytic responses to PR:PROJECT_SUMMARY inflammatory stimulation, with a particular focus on its function in inosine PR:PROJECT_SUMMARY metabolism and energy balance. Using mouse primary astrocytes exposed to PR:PROJECT_SUMMARY cytokine-induced activation, together with targeted metabolomic profiling and PR:PROJECT_SUMMARY pharmacological manipulation, we examined how Ent2 activity influences purine PR:PROJECT_SUMMARY metabolism and reactivity. Our findings show that inosine is an essential energy PR:PROJECT_SUMMARY substrate during inflammation and that Ent2 is required to regulate inosine PR:PROJECT_SUMMARY efflux and maintain ATP production. Loss of Ent2, or pharmacological inhibition PR:PROJECT_SUMMARY of inosine catabolism, disrupted energy homeostasis, impaired mitochondrial PR:PROJECT_SUMMARY function, and enhanced astrocytic reactivity. These results establish an PR:PROJECT_SUMMARY Ent2-inosine-PNP axis as a critical pathway linking purine metabolism to PR:PROJECT_SUMMARY astrocytic reactivity. PR:INSTITUTE Institute of Biomedical Sciences, Academia Sinica PR:LAST_NAME Chern PR:FIRST_NAME Yijuang PR:ADDRESS 128 Section 2, Academia Road, Nankang, Taipei, 115201, Taiwan PR:EMAIL bmychern@ibms.sinica.edu.tw PR:PHONE +886-2-2652-3913 #STUDY ST:STUDY_TITLE Equilibrative Nucleoside Transporter 2 Modulates Inosine Catabolism to Influence ST:STUDY_TITLE Astrocyte Metabolism and Reactivity ST:STUDY_SUMMARY In this study, we demonstrate that inosine functions as an essential energy ST:STUDY_SUMMARY substrate for astrocytes under inflammatory conditions. Targeted metabolomic ST:STUDY_SUMMARY datasets were generated from mouse primary astrocytes after 24 hours of cytokine ST:STUDY_SUMMARY cocktail treatment. Metabolomic profiling, combined with pharmacological ST:STUDY_SUMMARY approaches, revealed that Ent2 regulates inosine efflux and is critical for ST:STUDY_SUMMARY maintaining astrocytic energy balance. Pharmacological inhibition of inosine ST:STUDY_SUMMARY utilization in energy-producing pathways with Forodesine led to disrupted energy ST:STUDY_SUMMARY homeostasis and increased astrocytic reactivity. The datasets include both raw ST:STUDY_SUMMARY and processed metabolomic files. Metabolomic analyses were performed at the ST:STUDY_SUMMARY Metabolomics Core Facility, Agricultural Biotechnology Research Center, Academia ST:STUDY_SUMMARY Sinica, Taipei, Taiwan. ST:INSTITUTE Institute of Biomedical Sciences, Academia Sinica ST:LAST_NAME Chern ST:FIRST_NAME Yijuang ST:ADDRESS 128 Section 2, Academia Road, Nankang, Taipei, 115201, Taiwan ST:EMAIL bmychern@ibms.sinica.edu.tw ST:PHONE +886-2-26523913 #SUBJECT SU:SUBJECT_TYPE Cultured cells SU:SUBJECT_SPECIES Mus musculus SU:TAXONOMY_ID 10090 #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS WT_1_Ctrl WT_1_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_1_Ctrl.mzML SUBJECT_SAMPLE_FACTORS WT_2_Ctrl WT_2_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_2_Ctrl.mzML SUBJECT_SAMPLE_FACTORS WT_3_Ctrl WT_3_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_3_Ctrl.mzML SUBJECT_SAMPLE_FACTORS WT_4_Ctrl WT_4_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_4_Ctrl.mzML SUBJECT_SAMPLE_FACTORS WT_5_Ctrl WT_5_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_5_Ctrl.mzML SUBJECT_SAMPLE_FACTORS WT_6_Ctrl WT_6_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_6_Ctrl.mzML SUBJECT_SAMPLE_FACTORS WT_1_Cytokine WT_1_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_1_Cytokine.mzML SUBJECT_SAMPLE_FACTORS WT_2_Cytokine WT_2_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_2_Cytokine.mzML SUBJECT_SAMPLE_FACTORS WT_3_Cytokine WT_3_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_3_Cytokine.mzML SUBJECT_SAMPLE_FACTORS WT_4_Cytokine WT_4_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_4_Cytokine.mzML SUBJECT_SAMPLE_FACTORS WT_5_Cytokine WT_5_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_5_Cytokine.mzML SUBJECT_SAMPLE_FACTORS WT_6_Cytokine WT_6_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_6_Cytokine.mzML SUBJECT_SAMPLE_FACTORS WT_7_Cytokine WT_7_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_7_Cytokine.mzML SUBJECT_SAMPLE_FACTORS WT_1_CytokinePlusForo WT_1_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_1_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS WT_2_CytokinePlusForo WT_2_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-2𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_2_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS WT_3_CytokinePlusForo WT_3_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-3𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_3_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS WT_4_CytokinePlusForo WT_4_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-4𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=WT_4_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS WT_5_CytokinePlusForo WT_5_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-5𝝰/Forodesine Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_5_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS WT_6_CytokinePlusForo WT_6_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-6𝝰/Forodesine Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_6_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS WT_7_CytokinePlusForo WT_7_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-7𝝰/Forodesine Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=WT_7_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS KO_1_Ctrl KO_1_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent2 knockout | treatment:Vehicle Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_1_Ctrl.mzML SUBJECT_SAMPLE_FACTORS KO_2_Ctrl KO_2_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent3 knockout | treatment:Vehicle Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_2_Ctrl.mzML SUBJECT_SAMPLE_FACTORS KO_3_Ctrl KO_3_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent4 knockout | treatment:Vehicle Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_3_Ctrl.mzML SUBJECT_SAMPLE_FACTORS KO_4_Ctrl KO_4_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent5 knockout | treatment:Vehicle Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_4_Ctrl.mzML SUBJECT_SAMPLE_FACTORS KO_5_Ctrl KO_5_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent6 knockout | treatment:Vehicle Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_5_Ctrl.mzML SUBJECT_SAMPLE_FACTORS KO_6_Ctrl KO_6_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent7 knockout | treatment:Vehicle Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_6_Ctrl.mzML SUBJECT_SAMPLE_FACTORS KO_1_Cytokine KO_1_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent8 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_1_Cytokine.mzML SUBJECT_SAMPLE_FACTORS KO_2_Cytokine KO_2_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent9 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_2_Cytokine.mzML SUBJECT_SAMPLE_FACTORS KO_3_Cytokine KO_3_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent10 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_3_Cytokine.mzML SUBJECT_SAMPLE_FACTORS KO_4_Cytokine KO_4_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent11 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_4_Cytokine.mzML SUBJECT_SAMPLE_FACTORS KO_5_Cytokine KO_5_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent12 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_5_Cytokine.mzML SUBJECT_SAMPLE_FACTORS KO_6_Cytokine KO_6_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent13 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_6_Cytokine.mzML SUBJECT_SAMPLE_FACTORS KO_7_Cytokine KO_7_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent14 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_7_Cytokine.mzML SUBJECT_SAMPLE_FACTORS KO_1_CytokinePlusForo KO_1_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent15 knockout | treatment:TNF𝝰/IL-1𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_1_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS KO_2_CytokinePlusForo KO_2_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent16 knockout | treatment:TNF𝝰/IL-2𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_2_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS KO_3_CytokinePlusForo KO_3_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent17 knockout | treatment:TNF𝝰/IL-3𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_3_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS KO_4_CytokinePlusForo KO_4_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent18 knockout | treatment:TNF𝝰/IL-4𝝰/Forodesine Batch=B1; MS_ion Mode=negative; RAW_FILE_NAME=KO_4_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS KO_5_CytokinePlusForo KO_5_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent19 knockout | treatment:TNF𝝰/IL-5𝝰/Forodesine Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_5_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS KO_6_CytokinePlusForo KO_6_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent20 knockout | treatment:TNF𝝰/IL-6𝝰/Forodesine Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_6_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS KO_7_CytokinePlusForo KO_7_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent21 knockout | treatment:TNF𝝰/IL-7𝝰/Forodesine Batch=B2; MS_ion Mode=negative; RAW_FILE_NAME=KO_7_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_WT_1_Ctrl p_WT_1_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_1_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_WT_2_Ctrl p_WT_2_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_2_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_WT_3_Ctrl p_WT_3_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_3_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_WT_4_Ctrl p_WT_4_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_4_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_WT_5_Ctrl p_WT_5_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_5_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_WT_6_Ctrl p_WT_6_Ctrl Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_6_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_WT_1_Cytokine p_WT_1_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_1_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_WT_2_Cytokine p_WT_2_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_2_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_WT_3_Cytokine p_WT_3_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_3_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_WT_4_Cytokine p_WT_4_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_4_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_WT_5_Cytokine p_WT_5_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_5_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_WT_6_Cytokine p_WT_6_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_6_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_WT_7_Cytokine p_WT_7_Cytokine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_7_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_WT_1_CytokinePlusForo p_WT_1_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_1_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_WT_2_CytokinePlusForo p_WT_2_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-2𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_2_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_WT_3_CytokinePlusForo p_WT_3_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-3𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_3_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_WT_4_CytokinePlusForo p_WT_4_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-4𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_4_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_WT_5_CytokinePlusForo p_WT_5_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-5𝝰/Forodesine Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_5_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_WT_6_CytokinePlusForo p_WT_6_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-6𝝰/Forodesine Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_6_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_WT_7_CytokinePlusForo p_WT_7_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-7𝝰/Forodesine Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_WT_7_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_KO_1_Ctrl p_KO_1_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent2 knockout | treatment:Vehicle Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_1_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_KO_2_Ctrl p_KO_2_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent3 knockout | treatment:Vehicle Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_2_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_KO_3_Ctrl p_KO_3_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent4 knockout | treatment:Vehicle Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_3_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_KO_4_Ctrl p_KO_4_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent5 knockout | treatment:Vehicle Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_4_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_KO_5_Ctrl p_KO_5_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent6 knockout | treatment:Vehicle Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_5_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_KO_6_Ctrl p_KO_6_Ctrl Sample source:mouse primary astrocytes | Genotype:Ent7 knockout | treatment:Vehicle Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_6_Ctrl.mzML SUBJECT_SAMPLE_FACTORS p_KO_1_Cytokine p_KO_1_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent8 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_1_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_KO_2_Cytokine p_KO_2_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent9 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_2_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_KO_3_Cytokine p_KO_3_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent10 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_3_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_KO_4_Cytokine p_KO_4_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent11 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_4_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_KO_5_Cytokine p_KO_5_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent12 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_5_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_KO_6_Cytokine p_KO_6_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent13 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_6_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_KO_7_Cytokine p_KO_7_Cytokine Sample source:mouse primary astrocytes | Genotype:Ent14 knockout | treatment:TNF𝝰/IL-1𝝰 Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_7_Cytokine.mzML SUBJECT_SAMPLE_FACTORS p_KO_1_CytokinePlusForo p_KO_1_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent15 knockout | treatment:TNF𝝰/IL-1𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_1_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_KO_2_CytokinePlusForo p_KO_2_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent16 knockout | treatment:TNF𝝰/IL-2𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_2_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_KO_3_CytokinePlusForo p_KO_3_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent17 knockout | treatment:TNF𝝰/IL-3𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_3_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_KO_4_CytokinePlusForo p_KO_4_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent18 knockout | treatment:TNF𝝰/IL-4𝝰/Forodesine Batch=B1; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_4_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_KO_5_CytokinePlusForo p_KO_5_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent19 knockout | treatment:TNF𝝰/IL-5𝝰/Forodesine Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_5_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_KO_6_CytokinePlusForo p_KO_6_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent20 knockout | treatment:TNF𝝰/IL-6𝝰/Forodesine Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_6_CytokinePlusForo.mzML SUBJECT_SAMPLE_FACTORS p_KO_7_CytokinePlusForo p_KO_7_CytokinePlusForo Sample source:mouse primary astrocytes | Genotype:Ent21 knockout | treatment:TNF𝝰/IL-7𝝰/Forodesine Batch=B2; MS_ion Mode=positive; RAW_FILE_NAME=p_KO_7_CytokinePlusForo.mzML #COLLECTION CO:COLLECTION_SUMMARY Primary astrocytes were isolated from the brains of wild-type or ENT2-/- mice at CO:COLLECTION_SUMMARY postnatal day 1 (P1). On DIV27, cells were stimulated with a cytokine cocktail, CO:COLLECTION_SUMMARY and metabolites were extracted on DIV28 using 0.6N perchloric acid (PCA). CO:COLLECTION_PROTOCOL_FILENAME culture_and_collection_protocol.pdf CO:SAMPLE_TYPE Astrocyte cells #TREATMENT TR:TREATMENT_SUMMARY Ent2+/+ and Ent2-/- primary astrocytes were treated on DIV27 with TNFα (30 TR:TREATMENT_SUMMARY ng/mL) and IL-1α (3 ng/mL) for 24 hours to induce activation. To inhibit PNP TR:TREATMENT_SUMMARY activity, Forodesine (2 μM) was applied simultaneously with cytokine treatment. TR:TREATMENT_PROTOCOL_FILENAME Treatment_protocol_24h.pdf #SAMPLEPREP SP:SAMPLEPREP_SUMMARY Primary astrocytes were washed, digested, and subjected to metabolite extraction SP:SAMPLEPREP_SUMMARY using 0.6 N perchloric acid (PCA), followed by neutralization with K₂CO₃. SP:SAMPLEPREP_SUMMARY The clarified supernatants were collected and used for metabolomic profiling. SP:SAMPLEPREP_SUMMARY The remaining protein pellets were processed separately and retained for SP:SAMPLEPREP_SUMMARY concentration measurement. SP:SAMPLEPREP_PROTOCOL_FILENAME PCA_extraction.pdf SP:EXTRACT_STORAGE -80℃ #CHROMATOGRAPHY CH:CHROMATOGRAPHY_TYPE HILIC CH:INSTRUMENT_NAME Agilent 1290 Infinity II UPLC system CH:COLUMN_NAME ACQUITY UPLC BEH Amide (100 x 2.1 mm, 1.7 μm) CH:SOLVENT_A 100% Double-distilled Water; 15 mM ammonium acetate; 0.3% Ammonium hydroxide CH:SOLVENT_B 90% Acetonitrile/10% Double-distilled Water; 15 mM ammonium acetate; 0.3% Ammonium hydroxide CH:FLOW_GRADIENT 0–8 min, 90-50% B; 8–10 min, 50% B; 10–11 min, 50–90% B; 11–16 min, CH:FLOW_GRADIENT 90% B. (amide column) CH:FLOW_RATE 0.3 mL/min CH:COLUMN_TEMPERATURE 40℃ #ANALYSIS AN:ANALYSIS_TYPE MS AN:ANALYSIS_PROTOCOL_FILE UPLC-MS-protocol.pdf #MS MS:INSTRUMENT_NAME Agilent 6545XT QTOF MS:INSTRUMENT_TYPE QTOF MS:MS_TYPE ESI MS:ION_MODE NEGATIVE MS:MS_COMMENTS Data were acquired in both positive and negative full-scan modes (m/z MS:MS_COMMENTS 60–1500), processed using Agilent Qualitative Analysis 10.0 and Profinder MS:MS_COMMENTS B.10.00 software, and quantified based on peak area across treatments. #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS ion counts MS_METABOLITE_DATA_START Samples WT_1_Ctrl WT_2_Ctrl WT_3_Ctrl WT_4_Ctrl WT_5_Ctrl WT_6_Ctrl KO_1_Ctrl KO_2_Ctrl KO_3_Ctrl KO_4_Ctrl KO_5_Ctrl KO_6_Ctrl WT_1_Cytokine WT_2_Cytokine WT_3_Cytokine WT_4_Cytokine WT_5_Cytokine WT_6_Cytokine WT_7_Cytokine KO_1_Cytokine KO_2_Cytokine KO_3_Cytokine KO_4_Cytokine KO_5_Cytokine KO_6_Cytokine KO_7_Cytokine WT_1_CytokinePlusForo WT_2_CytokinePlusForo WT_3_CytokinePlusForo WT_4_CytokinePlusForo WT_5_CytokinePlusForo WT_6_CytokinePlusForo WT_7_CytokinePlusForo KO_1_CytokinePlusForo KO_2_CytokinePlusForo KO_3_CytokinePlusForo KO_4_CytokinePlusForo KO_5_CytokinePlusForo KO_6_CytokinePlusForo KO_7_CytokinePlusForo Factors Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Ent2 knockout | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Ent3 knockout | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Ent4 knockout | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Ent5 knockout | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Ent6 knockout | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Ent7 knockout | treatment:Vehicle Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Ent8 knockout | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Ent9 knockout | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Ent10 knockout | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Ent11 knockout | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Ent12 knockout | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Ent13 knockout | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Ent14 knockout | treatment:TNF𝝰/IL-1𝝰 Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-1𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-2𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-3𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-4𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-5𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-6𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Wild-type | treatment:TNF𝝰/IL-7𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Ent15 knockout | treatment:TNF𝝰/IL-1𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Ent16 knockout | treatment:TNF𝝰/IL-2𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Ent17 knockout | treatment:TNF𝝰/IL-3𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Ent18 knockout | treatment:TNF𝝰/IL-4𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Ent19 knockout | treatment:TNF𝝰/IL-5𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Ent20 knockout | treatment:TNF𝝰/IL-6𝝰/Forodesine Sample source:mouse primary astrocytes | Genotype:Ent21 knockout | treatment:TNF𝝰/IL-7𝝰/Forodesine Total protein 238.6 279.2 279.2 279.2 286 245.4 245.4 326.4 292.6 238.6 428 272.4 340 319.8 286 279.2 292.6 299.4 258.8 326.4 292.6 286 380.6 279.2 245.4 204.8 313 286 286 265.6 286 313 482 373.8 265.6 286 292.6 326.4 340 279.2 Fenclonine (IS) 42350 56665 50568 45674 42896 47375 47588 42220 45299 32683 34254 33098 57776 35086 53022 45630 45042 44186 41486 43074 32978 49393 36263 35539 33058 33704 42577 37435 36170 48954 39314 38638 37434 43977 45804 42255 41153 29117 32331 28619 2,3-BPG 2-HG 2869 2425 2669 2494 2977 2837 5157 3861 7375 3745 5624 3879 3408 2508 2607 2101 2015 2669 2376 4110 4960 5956 2694 4550 3494 3099 2365 2418 2367 4116 2745 3019 1635 4418 4063 4057 4009 2650 2918 3279 2-PG 3799 5073 4237 5048 4939 5697 4808 4423 4466 3770 3888 3966 4266 3468 3988 5413 4549 4762 5014 4591 3846 3801 3737 4241 4893 4239 4719 5148 3571 5303 5422 5115 5201 4023 4053 3953 4020 3744 4025 3752 3-PG 3702 5109 4208 7565 6064 7458 3188 3072 2217 4078 3943 4332 3666 4291 3955 6597 5644 5874 6059 2813 2203 1841 3383 3637 3620 4194 4436 4828 3397 4090 6023 5356 5023 2454 2808 1573 1505 3375 3142 3051 6PG Ala 4936 4467 4419 4560 5889 5869 8165 6596 9055 7126 9895 7646 6575 5513 5349 5311 5207 7295 6252 7235 7579 10284 9018 9734 7930 7541 3925 4117 5427 6670 6942 5821 5456 7257 6146 8642 8117 7375 7293 8335 alpha-KG Arg 1236 1154 1377 2257 1848 2119 3309 3364 3128 2436 2883 2371 805 593 629 1611 1163 874 561 1172 1431 1116 1115 1492 1007 659 921 819 931 1215 832 1698 1324 1299 1255 740 Asn 656 543 712 640 2117 1109 1848 1068 1383 822 1515 978 1287 563 747 1275 1310 2402 2502 2957 1791 1921 1375 1347 801 732 739 1835 1156 956 964 2355 1672 1997 1376 1439 1510 1530 Asp 23945 26196 27760 33812 31298 37396 44813 39982 45023 33779 38074 33035 38542 33123 33019 29647 31303 41985 40355 39057 42192 45690 31687 34169 32562 30689 16274 24592 23030 33433 29882 28047 26233 33434 31585 37418 30800 26824 31107 34632 Aconitic acid Citrate 193457 218911 228043 248817 246050 274165 344353 306507 353413 294301 338301 334096 246903 188894 209836 231530 226659 270663 271373 398336 381624 470786 363065 383168 388012 391898 204135 239838 212781 312244 333997 296915 283288 372968 335904 409219 377936 339688 377203 390486 Cys Cystine DHAP dTMP E4P F16BP F6P / G1P 2633 3577 1091 761 892 2993 4717 3243 1052 878 816 1988 1001 867 887 714 699 917 4616 678 6590 1979 986 1572 1114 619 2579 1053 4090 1162 685 783 2346 1638 1056 4589 693 962 Hypoxanthine 260457 472052 564042 490799 562723 649290 2040245 1883737 2154337 1832599 1843487 1908735 815655 594207 981655 1028615 891849 1160873 1117682 2567167 2433077 3061455 2656257 3267575 2581558 2519172 767278 909566 585044 1102577 1241075 1053624 905893 1490193 1418260 1685635 1538088 1151062 1365304 1508225 Fumarate G6P 588 542 588 562 1120 846 789 641 840 762 878 623 942 823 665 525 675 805 GAP(G3P) Glc Gln 25886 26716 30056 36606 45620 40048 57443 46748 66299 70935 79370 59403 53405 33334 44460 57018 48380 68087 47407 72214 67168 89179 92770 106520 77276 58121 31982 32419 33617 46641 54837 51974 39517 76922 63682 75564 65988 93898 94168 70088 Glu 41478 44034 55668 59146 55290 66878 87969 74910 97360 73126 82902 75528 85453 67048 76332 61316 64048 79658 81419 104062 102148 118389 91694 101833 89671 89358 66532 72578 72074 92771 83587 90664 78813 104870 94107 98436 90065 76995 90099 98468 Gly 5258 5595 6676 7901 7901 8750 14497 11186 14853 11412 19181 11389 10029 6378 8850 8049 10164 12071 9590 15057 14645 17387 14092 16065 16583 11318 6907 7003 5948 12124 10491 9217 8323 13643 12545 14383 12980 12255 13648 12769 His Ile 7586 8778 10122 9977 9632 9624 17956 14536 16137 11808 21309 12852 10847 7513 10048 10059 11828 11459 9561 11746 10571 13720 9337 10440 14499 9370 7020 8602 6209 12541 9946 9139 8122 11697 10970 12392 11548 8438 8646 8345 IMP 20459 21759 26755 27413 26371 30807 48827 38967 48711 41304 46747 49642 45115 22098 39177 36894 27546 42406 41226 45754 44474 71099 62809 66828 59963 46218 78609 76328 51313 88882 98565 89410 78272 72384 63766 91682 79917 59779 73598 72319 Inosine 1467 813 1575 2360 2018 2388 4949 5316 6598 4922 8254 4720 4046 6072 7887 4302 9478 11339 9217 8551 31872 28479 28089 30621 31477 33449 29842 Inositol 209795 249362 248053 261971 232432 267646 379990 300302 300549 248492 318280 311877 326887 260952 283210 217746 208981 315707 306166 404555 389143 387622 309464 387885 340849 268026 221254 287761 239622 323149 298866 307726 276889 370754 331028 327647 288054 262169 318677 300584 Lactate 5400 2182 1990 5126 2437 4564 4589 3289 4392 4216 70654 5580 2485 5489 2181 4163 49724 4681 3353 3644 6806 5802 8781 5727 54587 15942 2338 1957 4660 3323 4508 4980 3812 5503 5623 6249 5616 5359 5853 6881 Leu 7015 8074 8961 8751 9165 10058 14647 12538 14721 13555 23499 13320 9874 7298 9086 8575 10142 11178 10639 10498 11292 14498 12795 14155 15512 10234 5928 6993 6345 11271 10499 9540 9285 12282 11692 13233 11973 9199 10926 10981 Lys 7261 7205 8197 13359 13700 14598 15015 13786 14190 17568 24511 18179 5275 3083 4654 6879 7877 8913 7801 6452 6598 8682 10719 11809 11447 8566 3836 4410 3277 5848 8330 7769 6991 7243 6470 7847 6960 9881 10588 9461 M6P Malate 16607 14662 24742 25134 22089 28093 33710 29809 52313 39369 35777 36526 16343 16316 16471 16153 19027 21667 18941 23518 27468 41092 29445 31547 26644 25791 11034 12465 17320 22401 22408 20099 16947 23043 23449 29450 27057 21071 24151 27007 Met OAA PEP 10082 15761 10908 14146 12437 15517 10452 10837 9488 10190 10062 12173 10655 9700 9159 16344 12198 12490 13454 10091 8509 8023 9489 10375 11577 11486 12359 13472 9960 12129 14466 11406 13283 9768 9097 7323 7818 10129 11218 9429 Phe 1751 1874 2410 2629 1855 2804 4431 3952 4143 3125 6843 3805 3009 2050 2238 2016 2709 2927 2537 2803 2905 3694 2888 3576 4297 2083 1047 1921 1492 3109 2516 2287 1757 3971 2617 3492 2671 2292 3132 2385 Pro 5083 4584 5415 8437 4579 9204 8635 6491 8128 8643 13071 10290 6582 5733 5810 7239 8537 10889 8838 9239 10189 11509 10781 14057 12487 10654 4129 5656 5053 9191 10765 10336 8857 9150 8371 8404 8142 9609 11106 11089 Pyruvate R5P 586 638 1039 1162 1714 1530 880 1125 1135 1846 1086 665 718 784 1187 1009 1372 1768 1364 1496 1710 1774 1000 1052 1004 564 1559 1620 1480 1202 1497 1340 1063 958 1159 1307 996 Ru5P S7P Ser 9756 8735 9130 10748 10412 11180 18957 14919 17347 13008 22772 13992 14776 11968 11807 10288 12370 14289 12380 19501 18824 21520 15937 17540 20462 13220 9405 9683 10184 17383 11965 11470 10050 17865 16072 17584 15135 14214 14147 13608 Succinate 2579 1831 2622 3642 3789 4671 4372 3666 5648 5587 7903 6481 2826 2304 2946 4084 4292 5301 4531 4432 6190 6509 7318 8633 6909 8040 2870 2337 2645 4321 5688 5629 4581 4850 5060 5336 5291 7704 7958 8057 Thr 859 545 1488 928 1449 1018 1985 1237 584 523 637 1137 953 619 1202 1288 1172 1281 641 1099 594 712 1117 542 724 680 Thymidine Thymine Trp 506 856 748 893 2135 1139 1484 1383 2533 1423 783 665 1427 571 653 701 909 1228 608 1661 507 745 676 747 528 1143 1117 960 630 Tyr 3633 4137 3689 4731 5008 5677 5823 5091 5477 5450 8315 4744 5005 3703 4576 3942 5285 5209 4174 4752 3860 4757 3451 4818 5898 3487 3117 4277 1836 5184 4166 4376 3867 4784 5659 4679 4064 4014 4005 3534 UDP 1022 2362 1390 3812 2669 4010 3976 4147 4589 4202 5806 4730 2642 1162 2778 2313 3033 3513 3080 5965 2621 5077 5465 6807 6496 5317 4289 3384 3777 6191 6475 5763 5050 6771 7583 6120 5612 4251 4244 4837 UMP 2714 23369 22671 17176 16472 19568 29218 29606 27877 17540 9012 16419 18803 14130 16403 13300 11706 14846 16235 27566 6153 33665 21887 17704 20630 14496 12799 20009 17347 28690 15270 14374 13805 25061 23708 21595 26281 3028 3465 3952 Uracil Uridine UTP 6575 8204 8950 8433 8360 9027 18397 16078 16960 13513 13498 13416 10149 7693 9349 8089 7555 10328 8653 37251 47328 42349 25682 28479 25224 22101 13858 24606 14671 31069 21846 21632 17839 39779 30467 30667 30142 26290 29601 27613 Val 4349 5373 5458 6312 6186 6476 9268 7881 8653 7792 13824 7660 5978 4875 5664 6240 7102 7021 6303 6721 6590 7978 6514 6970 10027 5670 815 4833 2660 7063 6322 5596 5623 6508 6274 6645 6276 5411 6211 5488 Xanthine 4259 5994 7747 15328 17806 16441 19077 16220 21914 31174 27874 19204 10183 7291 12469 17198 19956 19638 19863 14023 11963 19786 23520 24650 22446 20647 7401 9118 6257 11506 17759 13644 13263 10000 8990 12667 14302 9286 9881 12207 Xanthosine XMP Xu5P Adenosine diphosphate ribose MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name Formula Mass RT CAS ID Total protein Fenclonine (IS) C9 H10 Cl N O2 199.040 1.9 14173-39-8 2,3-BPG C3 H8 O10 P2 265.959 5.6 138-81-8 2-HG C5 H8 O5 148.037 4.5 13095-48-2 2-PG C3 H7 O7 P 185.993 5.6 2553-59-5 3-PG C3 H7 O7 P 185.993 5.6 820-11-1 6PG C6 H13 O10 P 276.025 5.7 921-62-0 Ala C3 H7 N O2 89.047 3.7 56-41-7 alpha-KG C5 H6 O5 146.022 3.9 328-50-7 Arg C6 H14 N4 O2 174.111 6.1 74-79-3 Asn C4 H8 N2 O3 132.053 4.1 70-47-3 Asp C4 H7 N O4 133.038 4.6 56-84-8 Aconitic acid C6 H6 O6 174.016 4.9 499-12-7 Citrate C6 H8 O7 192.027 5.7 77-92-9 Cys C3 H7 N O2 S 121.020 5.2 52-90-4 Cystine C6 H12 N2 O4 S2 240.024 5.2 56-89-3 DHAP C3 H7 O6 P 169.998 4.8 57-04-5 dTMP C10 H15 N2 O8 P 322.057 4.5 365-07-1 E4P C4 H9 O7 P 200.009 5.2 585-18-2 F16BP C6 H14 O12 P2 339.996 6.2 488-69-7 F6P / G1P C6 H13 O9 P 260.029 5.5 643-13-0 / 59-56-3 Hypoxanthine C5 H4 N4 O 136.039 1.9 68-94-0 Fumarate C4 H4 O4 116.011 4.1 110-17-8 G6P C6 H13 O9 P 260.029 5.9 56-73-5 GAP(G3P) C3 H7 O6 P 169.998 5.2 591-57-1 Glc C6 H12 O6 180.063 3.2 50-99-7 Gln C5 H10 N2 O3 146.069 4.0 56-85-9 Glu C5 H9 N O4 147.053 4.5 56-86-0 Gly C2 H5 N O2 75.032 4.1 56-40-6 His C6 H9 N3 O2 155.070 4.4 71-00-1 Ile C6 H13 N O2 131.095 2.4 73-32-5 IMP C10 H13 N4 O8 P 348.046 5.4 131-99-7 Inosine C10 H12 N4 O5 268.081 2.2 58-63-9 Inositol C6 H12 O6 180.063 4.4 87-89-8 Lactate C3 H6 O3 90.032 2.2 50-21-5 Leu C6 H13 N O2 131.095 2.4 61-90-5 Lys C6 H14 N2 O2 146.105 6.4 56-87-1 M6P C6 H13 O9 P 260.030 5.5 3672-15-9 Malate C4 H6 O5 134.021 4.7 6915-15-7 Met C5 H11 N O2 S 149.051 2.5 63-68-3 OAA C4 H4 O5 132.006 5.4 328-42-7 PEP C3 H5 O6 P 167.982 5.6 138-08-9 Phe C9 H11 N O2 165.079 2.2 63-91-2 Pro C5 H9 N O2 115.063 3.1 147-85-3 Pyruvate C3 H4 O3 88.016 1.7 127-17-3 R5P C5 H11 O8 P 230.018 5.4 4300-28-1 Ru5P C5 H11 O8 P 230.019 5.1 551-85-9 S7P C7 H15 O10 P 290.040 5.4 2646-35-7 Ser C3 H7 N O3 105.042 4.1 56-45-1 Succinate C4 H6 O4 118.026 4.5 110-15-6 Thr C4 H9 N O3 119.058 3.6 72-19-5 Thymidine C10 H14 N2 O5 242.090 1.3 50-89-5 Thymine C5 H6 N2 O2 126.043 1.3 65-71-4 Trp C11 H12 N2 O2 204.089 2.3 73-22-3 Tyr C9 H11 N O3 181.073 2.9 60-18-4 UDP C9 H14 N2 O12 P2 404.001 5.7 58-98-0 UMP C9 H13 N2 O9 P 324.035 5.3 58-97-9 Uracil C4 H4 N2 O2 112.027 1.7 66-22-8 Uridine C9 H12 N2 O6 244.070 2.0 58-96-8 UTP C9 H15 N2 O15 P3 483.967 6.2 63-39-8 Val C5 H11 N O2 117.079 2.9 72-18-4 Xanthine C5 H4 N4 O2 152.033 2.5 69-89-6 Xanthosine C10 H12 N4 O6 284.076 3.4 146-80-5 XMP C10 H13 N4 O9 P 364.042 5.7 523-98-8 Xu5P C5 H11 O8 P 230.019 5.2 60802-29-1 Adenosine diphosphate ribose C15 H23 N5 O14 P2 559.0717 4.9 METABOLITES_END #END